NCT06088836

Brief Summary

The aim of this study is to compare the incentive spirometry volume and analgesic efficacy of ultrasound guided continuous Retrolaminar block and continuous Erector spinae plain block in patients with multiple rib fractures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 3, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 18, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

October 18, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 18, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 18, 2025

Completed
Last Updated

June 22, 2025

Status Verified

June 1, 2025

Enrollment Period

1.7 years

First QC Date

October 3, 2023

Last Update Submit

June 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Maximum inspired volume

    Maximum inspired volume will be measure by incentive spirometry which indicate less pain. Inspiratory capacity (IC) measured by Incentive Spirometry before the block, 30 minutes, 60 minutes after the blocks and then every six hours for subsequent 4 days.

    4 days after intervention.

Secondary Outcomes (9)

  • Daily and total rescue analgesics consumption.

    24 hours after intervention.

  • Intensive care length of stay.

    28 days after intervention

  • Hospital length of stay.

    28 days after intervention

  • pH

    4 days after intervention.

  • PaO2

    4 days after intervention.

  • +4 more secondary outcomes

Study Arms (2)

Group I (Retrolaminar block group)

EXPERIMENTAL

Patients received ultrasound guided Retrolaminar block bolus dose of 20 ml 0.25% bupivacaine then continuous infusion at a rate of 0.1 mL/kg/hr. for 4 days

Drug: Retrolaminar block group

Group II (Erector spinae plane block group)

EXPERIMENTAL

Patients received ultrasound guided Erector spinae plane block bolus dose of 20 ml 0.25% bupivacaine then continuous infusion at a rate of 0.1 mL/kg/hr. for 4 days

Drug: Erector spinae plane block group.

Interventions

Under complete aseptic precautions and sterilization and in sitting position, A high-frequency linear ultrasound probe (6-11 MHz) was placed into a longitudinal orientation in the paraspinous line 1 cm from the midline. Lamina appeared as a continuous line interrupted by the intra laminar spaces. local infiltration of needle insertion site with 3ml of 2.0 % lidocaine was done Then, an 18-gauge Tuohy needle was inserted in plane 1 cm lateral to the spinous process using ultrasound imaging and advanced caudally or cranially until it contacts the lamina.

Group I (Retrolaminar block group)

Under complete aseptic precautions and sterilization and in sitting position, A high-frequency ultrasound transducer was placed in a longitudinal orientation 3 cm lateral to the midline midway between the uppermost and the lowest fractured rib to identify counting of ribs using ultrasound three muscles were identified as superficial to the hyperechoic transverse process shadow as follows: trapezius, rhomboid major, and erector spinae. However, when the rhomboid major muscle disappears this indicates that we are at the level of the seventh thoracic vertebra. local infiltration of needle insertion site with 3ml of 2.0 % lidocaine was done. Then, an 18-gauge Tuohy needle was inserted in cranial-caudal direction towards transverse process (TP) in-plane to the US transducer until needle touched the TP crossing all the muscles

Group II (Erector spinae plane block group)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age from 18 to 65 years old.
  • Both sexes.
  • Patients with unilateral multiple traumatic rib fractures (≥ 3 ribs).

You may not qualify if:

  • st ken refusal.
  • Patients with any contraindication for regional block as:
  • Bleeding disorders.
  • Infection at the injection site.
  • Patients with hemodynamic instability.
  • Patients with known hypersensitivity to the study drugs
  • Unconscious patients
  • Patients with significant trauma outside the chest wall e.g., acute spine or pelvic fracture, severe traumatic brain or spinal cord injury, or abdominal visceral injuries
  • Patients with significant lung contusions, pneumothorax, flail chest
  • Chronic opioid users.
  • Uncooperative patients and patients with psychiatric illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University

Tanta, El-Gharbia, 31527, Egypt

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer of Anesthesia, Surgical ICU and Pain Medicine Master's degree of Anesthesia, Surgical ICU And Pain Medicine

Study Record Dates

First Submitted

October 3, 2023

First Posted

October 18, 2023

Study Start

October 18, 2023

Primary Completion

June 18, 2025

Study Completion

June 18, 2025

Last Updated

June 22, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author.

Locations